logo

Latest Financial Updates

Read latest financial news update from our blog

CytomX Therapeutics: Updated Outlook For Late 2025 (NASDAQ:CTMX)
CytomX Therapeutics: Updated Outlook For Late 2025 (NASDAQ:CTMX)

I have my PhD in biochemistry and have worked for years analyzing clinical trials and biot...

Admin | Finance | 2 weeks ago

Pathway acquired by US telehealth firm Doximity for $63 million USD
Pathway acquired by US telehealth firm Doximity for $63 million USD

Doximity now beta testing a product with Pathway's AI-powered search technology and medica...

Admin | Finance | 2 weeks ago

Perle Scores $9M Seed Funding Round
Perle Scores $9M Seed Funding Round

Perle Scores $9M Seed Funding Round Back to Home SAN FRANCISCO, CA, Perle, an AI training...

Admin | Finance | 2 weeks ago

Client Challenge
Client Challenge

A required part of this site couldn’t load. This may be due to a browser extension, networ...

Admin | Finance | 2 weeks ago

OneSkin Grabs $20M Series A Round
OneSkin Grabs $20M Series A Round

OneSkin Grabs $20M Series A Round Back to Home SAN FRANCISCO, CA, OneSkin, the pioneering...

Admin | Finance | 2 weeks ago

August Health Receives $29M Series B Round
August Health Receives $29M Series B Round

August Health Receives $29M Series B Round Back to Home SAN FRANCISCO, CA, August Health...

Admin | Finance | 2 weeks ago

Zymeworks Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:ZYME)
Zymeworks Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:ZYME)

Seeking Alpha's transcripts team is responsible for the development of all of our transcri...

Admin | Finance | 2 weeks ago

Zymeworks Inc. (ZYME) Q2 2025 Earnings Call Transcript
Zymeworks Inc. (ZYME) Q2 2025 Earnings Call Transcript

Zymeworks Inc. (NASDAQ:ZYME) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET C...

Admin | Finance | 2 weeks ago

Join Our Newsletter

join our newsletter to receive update from us